2m 2m 2m 2m 2m 2m 2m
SCYNEXIS (SCYX)
NASDAQ
$5.18+$0.06 (+1.13%)
Price as of Oct 02, 2026 7:56 PM EDT- $53.4MMarket Cap
- -20.00%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
SCYNEXIS (SCYX)
$5.18+$0.06 (+1.13%)
SCYX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.12 | ||
Change | -$0.25 (-4.66%) | ||
Open | $5.32 | ||
High | $5.51 | ||
Low | $5.09 | ||
Previous Close | $5.37 | ||
Volume | 132,401 | ||
30-Day Average Volume | 471,525 | ||
1-Week Change | 16.63% | ||
1-Month Change | -1.92% | ||
1-Year Change | -20.00% | ||
3-Year Change | -70.64% | ||
5-Year Change | -87.62% | ||
Fundamentals | |||
Shares Outstanding | 9.9M | ||
Total Assets | $75.0M | ||
Market Cap | $53.4M | ||
Enterprise Value | $42.9M | ||
Period: QTR TTM FY | |||
Revenue | $235,000.00 | ||
Net Income | $7.4M | ||
Free Cash Flow | -$14.9M | ||
EBIT | $7.4M | ||
EBITDA | $7.4M | ||
Net Working Capital | $50.4M | ||
EPS | $0.63 | ||
Enterprise Value/EBITDA | 6 | ||
Enterprise Value/Revenue | 183 | ||
P/B | 1 | ||
P/E | 9 | ||
PEG | 0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 8 | ||
Last Split Date | 06/01/2026 | ||
Earnings & Revenue